Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms
The protein arginine methyltransferase 5 (PRMT5) as the major type II arginine methyltransferase catalyzes the mono- and symmetric dimethylation of arginine residues in both histone and non-histone proteins. Recently, increasing evidence has demonstrated that PRMT5 plays an indispensable role in the...
Guardado en:
Autores principales: | Yingqing Chen, Xiaomin Shao, Xiangge Zhao, Yuan Ji, Xiaorong Liu, Peixuan Li, Mingyu Zhang, Qianqian Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/21949dc41c81459f896375b78c91734d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies
por: Wafaa Abumustafa, et al.
Publicado: (2022) -
Structure, Activity and Function of the PRMT2 Protein Arginine Methyltransferase
por: Vincent Cura, et al.
Publicado: (2021) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
por: Tandon N, et al.
Publicado: (2016) -
Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease
por: Qiuyu Cai, et al.
Publicado: (2021) -
Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
por: Xiaomei Lu, et al.
Publicado: (2019)